The Biden-Harris administration’s Department of Health and Human Services (HHS) announced it is reversing the Trump administration’s decision to end taxpayer funding for experimental research that uses fetal tissue derived from aborted babies.
The National Institutes of Health (NIH), an agency under the authority of HHS, announced Friday an “Update on Changes to NIH Requirements Regarding Proposed Human Fetal Tissue Research”
Last week, legal watchdog organization Judicial Watch provided a nearly 600-page report that included uncovered emails of conversations between Food and Drug Administration (FDA) employees and the California-based biomedical company Advanced Bioscience Resources (ABR). The emails revealed the U.S. government had been buying and trafficking “fresh” aborted baby body parts.
According to the report, the FDA purchased the body parts, which were derived from babies aborted at up to 24-weeks’ gestation, in order to engineer humanized mice and perform experimental drug research.
The Federalist reported on the Judicial Watch revelation:
Emails between FDA officials and ABR employees reveal disturbing conversations as they collaborate to buy and sell aborted fetuses. Records indicate ABR was paid $12,000 upfront per baby, some survivable out of the womb, between the gestational age of 16-24 weeks. Most purchases are for intact thymuses and livers shipped “Fresh; on wet ice.”
With the callousness of picking a cut of meat from a butcher shop, an FDA doctor requests tissue samples be procured from a baby boy, as they claim “It is strongly preferred to have a male fetus if at all possible … [but] undetermined sex or female is better than no tissue.”
Read More Here.